Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Frick

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Empirical Research on Human Research Ethics : JERHRE|July 3, 2016
Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug TrialsKathleen M MacQueen, Natalie T Eley, Mike Frick, et al.
The Lancet. Respiratory Medicine|March 26, 2023
Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatmentMolebogeng X Rangaka, Mike Frick, Gavin Churchyard, et al.
The Lancet. Respiratory Medicine|January 25, 2024
What is next for BCG revaccination to prevent tuberculosis?Richard G White, Andrew J Fiore-Gartland, Willem A Hanekom, et al.
Vaccine|October 23, 2023
Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine developmentMonika M Looney, Mark Hatherill, Munyaradzi Musvosvi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trialsLindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
Nature Medicine|January 10, 2023
The 1/4/6x24 campaign to cure tuberculosis quicklyLindsay McKenna, Mike Frick, Ketholelie Angami, et al.
The Lancet. Infectious Diseases|June 30, 2025
The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?Jason R Andrews, Salome Charalambous, Gavin Churchyard, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 8, 2022
End-point definition and trial design to advance tuberculosis vaccine developmentAlberto L Garcia-Basteiro, Richard G White, Dereck Tait, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Empirical Research on Human Research Ethics : JERHRE|July 3, 2016
Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug TrialsKathleen M MacQueen, Natalie T Eley, Mike Frick, et al.
The Lancet. Respiratory Medicine|March 26, 2023
Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatmentMolebogeng X Rangaka, Mike Frick, Gavin Churchyard, et al.
The Lancet. Respiratory Medicine|January 25, 2024
What is next for BCG revaccination to prevent tuberculosis?Richard G White, Andrew J Fiore-Gartland, Willem A Hanekom, et al.
Vaccine|October 23, 2023
Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine developmentMonika M Looney, Mark Hatherill, Munyaradzi Musvosvi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trialsLindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
Nature Medicine|January 10, 2023
The 1/4/6x24 campaign to cure tuberculosis quicklyLindsay McKenna, Mike Frick, Ketholelie Angami, et al.
The Lancet. Infectious Diseases|June 30, 2025
The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?Jason R Andrews, Salome Charalambous, Gavin Churchyard, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 8, 2022
End-point definition and trial design to advance tuberculosis vaccine developmentAlberto L Garcia-Basteiro, Richard G White, Dereck Tait, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Pageof 3